WebFind information on Prochlorperazine (Compazine, Compro) in Davis’s Drug Guide including dosage, side effects, interactions, nursing implications, mechanism of action, … Prochlorperazine, formerly sold under the brand name Compazine among others, is a medication used to treat nausea, migraines, schizophrenia, psychosis and anxiety. It is a less preferred medication for anxiety. It may be taken by mouth, rectally, injection into a vein, or injection into a muscle. Common side effects include sleepiness, blurry vision, low blood pressure, an…
Compazine: Package Insert - Drugs.com
WebApr 15, 2024 · The diagnosis was revised to antip200 pemphigoid. Initial treatment with prednisolone and dapsone gave sufficient disease control, but dapsone was switched to mycophenolate mofetil due to headache. At a dose of prednisolone 20mg once a day (0.25 mg/kg daily) and mycophenolate mofetil 500mg twice a day, he sustained a flare of blisters. WebOndansetron may be a useful medication in the treatment regimen of migraine patients in the pediatric emergency department. Preliminary data suggest that ondansetron is … fod gent contact
Compazine Oral Reviews and User Ratings: Effectiveness, Ease …
WebCompazine is prochlorperazine which is an antipsychotic, meaning it's typically used for schizophrenia and the like. I had to be given Ativan and Benadryl in order to combat the effects and these calming medications only worked to a small extent. If you are getting a migraine cocktail, PLEASE consider asking for a different combination of ... WebProchlorperazine General Type: anti-psychotic and anti-emetic Dosage Forms: 5, 10 Routes of Administration: IV, PO Common Trade Names: Compazine Adult Dosing Headache 10mg IV (slow push or in 1L IVF) Nausea/Vomiting 5-10mg PO or IV q6-8 hours Max: 40mg/day Pediatric Dosing Nausea/vomiting, severe 2 yo and older, 9-14 kg WebProchlorperazine (Compazine®) 5 - 10 mg IV Risk of QTc prolongation Butyrophenones Droperidol (Inapsine®)1 Haloperidol (Haldol®) Third Line Agents 0.625 mg IV 1 mg IV Requires 2 - 3 hours of EKG monitoring Avoid in patients with prolonged QTc interval Risk of QTc prolongation precludes its use as a first-line agent Alternative to droperidol fo dgfip 31